Since 2013, the ITOMIC triple negative breast cancer trial has been on the leading edge of where cancer advances are going... equipping physicians and patients with personalized information about how to treat their cancer. To date, 31 patients have been enrolled in the trial, 28 of whom are South Sound CARE patients. The ITOMIC trial has opened up an avenue for this innovative approach for patients with an incurable form of breast cancer. The study is getting international attention in scientific articles... and now in the New York Times.
Related Articles
At Rush, we believe in giving back to the communities we live and work in. We were proud to partner with incredible organizations in 2022 that serve...
Each and every one of us knows someone - a parent, a child, a friend, a colleague - who has suffered from cancer. Thankfully, more and more people...
We are excited and honored to announce that The Rush Companies is in the top 100 Puget Sound Business Journal's Best Worplaces, Large Company category